Literature DB >> 19396958

Versatility of choline metabolism and choline-binding proteins in Streptococcus pneumoniae and commensal streptococci.

Regine Hakenbeck1, Abderrahim Madhour, Dalia Denapaite, Reinhold Brückner.   

Abstract

The pneumococcal choline-containing teichoic acids are targeted by cholinebinding proteins (CBPs), major surface components implicated in the interaction with host cells and bacterial cell physiology. CBPs also occur in closely related commensal species, Streptococcus oralis and Streptococcus mitis, and many strains of these species contain choline in their cell wall. Physiologically relevant CBPs including cell wall lytic enzymes are highly conserved between Streptococcus pneumoniae and S. mitis. In contrast, the virulence-associated CBPs, CbpA, PspA and PcpA, are S. pneumoniae specific and are thus relevant for the characteristic properties of this species.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396958     DOI: 10.1111/j.1574-6976.2009.00172.x

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  29 in total

Review 1.  Envelope Structures of Gram-Positive Bacteria.

Authors:  Mithila Rajagopal; Suzanne Walker
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

2.  Characterization and identification of a novel candidate vaccine protein through systematic analysis of extracellular proteins of Erysipelothrix rhusiopathiae.

Authors:  Fang Shi; Yohsuke Ogawa; Akiyuki Sano; Tomoyuki Harada; Jiro Hirota; Masahiro Eguchi; Eiji Oishi; Yoshihiro Shimoji
Journal:  Infect Immun       Date:  2013-09-09       Impact factor: 3.441

3.  Structural basis for the specific recognition of dual receptors by the homopolymeric pH 6 antigen (Psa) fimbriae of Yersinia pestis.

Authors:  Rui Bao; Manoj K M Nair; Wai-kwan Tang; Lothar Esser; Annapurna Sadhukhan; Robin L Holland; Di Xia; Dieter M Schifferli
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-31       Impact factor: 11.205

Review 4.  Microbial modulation of host immunity with the small molecule phosphorylcholine.

Authors:  Sarah E Clark; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

5.  Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins.

Authors:  Eliane N Miyaji; Cintia F M Vadesilho; Maria Leonor S Oliveira; André Zelanis; David E Briles; Paulo L Ho
Journal:  Clin Vaccine Immunol       Date:  2014-12-17

6.  Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage.

Authors:  Sabine M P J Prevaes; Willem J B van Wamel; Corné P de Vogel; Reinier H Veenhoven; Elske J M van Gils; Alex van Belkum; Elisabeth A M Sanders; Debby Bogaert
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

7.  CovR Regulates Streptococcus mutans Susceptibility To Complement Immunity and Survival in Blood.

Authors:  Lívia A Alves; Ryota Nomura; Flávia S Mariano; Erika N Harth-Chu; Rafael N Stipp; Kazuhiko Nakano; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

8.  The genome of Streptococcus mitis B6--what is a commensal?

Authors:  Dalia Denapaite; Reinhold Brückner; Michael Nuhn; Peter Reichmann; Bernhard Henrich; Patrick Maurer; Yvonne Schähle; Peter Selbmann; Wolfgang Zimmermann; Rolf Wambutt; Regine Hakenbeck
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

Review 9.  Serotype-independent pneumococcal vaccines.

Authors:  Eliane Namie Miyaji; Maria Leonor Sarno Oliveira; Eneas Carvalho; Paulo Lee Ho
Journal:  Cell Mol Life Sci       Date:  2012-12-27       Impact factor: 9.261

10.  Mapping the laminin receptor binding domains of Neisseria meningitidis PorA and Haemophilus influenzae OmpP2.

Authors:  Noha M Abouseada; Mahde Saleh A Assafi; Jafar Mahdavi; Neil J Oldfield; Lee M Wheldon; Karl G Wooldridge; Dlawer A A Ala'Aldeen
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.